Chinese researchers have achieved the world’s first successful treatment of a liver failure patient using ex vivo perfusion ...

"We have an available organ." Thousands of people never live long enough to hear those words. In fact, in the United States, 13 people die every day waiting for an organ transplant that never comes.

Upstream process intensification using perfusion cell culture has become a necessity for meeting today’s demand in monoclonal antibodies (mAbs) bioprocessing. By sustaining higher viable cell ...